Xcout Intel
BlueRock Therapeutics
BlueRock Therapeutics is a clinical-stage cell therapy company headquartered in Cambridge, Massachusetts, focused on developing engineered cellular medicines for degenerative conditions.
Subscribe to see BlueRock Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BlueRock Therapeutics at a glance
BlueRock Therapeutics is a biotechnology company headquartered in United States. Its most recent funding round, Series A, raised $225M in December 2016. Xcout tracks 14 named people at BlueRock Therapeutics, including Seth Ettenberg (President and Chief Executive Officer).
BlueRock Therapeutics leadership
- Seth EttenbergPresident and Chief Executive Officer
- Stefan OelrichBoard Chair Global President, Bayer Pharmaceuticals Division and Board of Management, Bayer AG
- Craig BeasleyChief Technology Officer
- Amit RakhitChief Development and Medical Officer
- Melissa MudrickChief Operations and Compliance Officer
- Alan StevensonGeneral Counsel
8 more named people on record for BlueRock Therapeutics, with roles, board committees and tenure — see the full roster →
BlueRock Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $225M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
BlueRock Therapeutics competitors
A few of BlueRock Therapeutics's closest competitors — see the full list of competitors and alternatives →
Blue Cell Therapeutics is a biotechnology company founded in Copenhagen that focuses on revolutionizing the treatment of erectile dysfunction using specialized cell therapy.
Cimeio Therapeutics is a privately held, applied gene editing, cellular, and immunotherapy company headquartered in Cambridge, Massachusetts. Founded in 2020, the company is dedicated to transforming hematopoietic stem cell transplantation and cellular therapies.
BlueWhale Bio, Inc. is dedicated to accelerating the growth and adoption of cell-based therapies by pioneering next-generation cell therapy manufacturing.
Be Biopharma is a biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on developing engineered B cell therapies.
Century Therapeutics is an innovative biotechnology company headquartered in Philadelphia, Pennsylvania. Its mission is to develop allogeneic, iPSC-derived NK and T cell therapies that are designed to be more effective, tolerable, and accessible.
Get BlueRock Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on BlueRock Therapeutics in Xcout Intel
- 14 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access